Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$7.61 - $8.63 $3,713 - $4,211
-488 Reduced 0.85%
56,877 $437,000
Q4 2023

Feb 13, 2024

SELL
$5.7 - $9.14 $1,322 - $2,120
-232 Reduced 0.4%
57,365 $503,000
Q3 2023

Nov 13, 2023

BUY
$6.35 - $8.16 $17,640 - $22,668
2,778 Added 5.07%
57,597 $419,000
Q2 2023

Aug 04, 2023

BUY
$3.14 - $6.61 $1,139 - $2,399
363 Added 0.67%
54,819 $362,000
Q1 2023

May 12, 2023

BUY
$2.97 - $4.81 $3,219 - $5,214
1,084 Added 2.03%
54,456 $185,000
Q4 2022

Feb 10, 2023

SELL
$2.63 - $3.45 $510 - $669
-194 Reduced 0.36%
53,372 $148,000
Q3 2022

Nov 14, 2022

BUY
$2.71 - $4.22 $2,051 - $3,194
757 Added 1.43%
53,566 $154,000
Q2 2022

Aug 12, 2022

SELL
$3.17 - $5.0 $7,430 - $11,720
-2,344 Reduced 4.25%
52,809 $183,000
Q1 2022

May 13, 2022

SELL
$4.27 - $6.27 $16,571 - $24,333
-3,881 Reduced 6.57%
55,153 $260,000
Q4 2021

Feb 11, 2022

SELL
$5.7 - $8.48 $10,071 - $14,984
-1,767 Reduced 2.91%
59,034 $357,000
Q3 2021

Nov 12, 2021

SELL
$5.52 - $15.83 $7,976 - $22,874
-1,445 Reduced 2.32%
60,801 $368,000
Q2 2021

Aug 13, 2021

BUY
$9.02 - $12.72 $561,458 - $791,769
62,246 New
62,246 $779,000
Q4 2018

Feb 13, 2019

SELL
$1.15 - $6.45 $93,319 - $523,398
-81,147 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$3.22 - $6.33 $4,929 - $9,691
1,531 Added 1.92%
81,147 $501,000
Q2 2018

Aug 08, 2018

BUY
$5.39 - $8.96 $71,956 - $119,616
13,350 Added 20.15%
79,616 $509,000
Q1 2018

May 07, 2018

SELL
$6.69 - $17.96 $106,819 - $286,767
-15,967 Reduced 19.42%
66,266 $462,000
Q4 2017

Feb 09, 2018

BUY
$10.87 - $13.9 $2,967 - $3,794
273 Added 0.33%
82,233 $1.04 Million
Q3 2017

Nov 09, 2017

BUY
$11.86 - $17.34 $972,045 - $1.42 Million
81,960
81,960 $974,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $671M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.